BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210303T130000
DTEND;TZID=America/New_York:20210303T170000
DTSTAMP:20260501T045459
CREATED:20210301T175856Z
LAST-MODIFIED:20210301T175856Z
UID:2479-1614776400-1614790800@www.ctnnortheastnode.org
SUMMARY:Reducing Disparities in SUD treatment among African Americans: A way forward for CTN Research - Day One
DESCRIPTION:CTN Virtual Workshop organized by the Minority Interest Group. \nPrior research found that African Americans (AAs): a) enter treatment later in the course of their addiction trajectory\, b) are more likely to drop out of treatment\, and c) have poorer treatment outcomes than non-Hispanic Whites. \nThis workshop will provide a) an overview of SUD treatments and outcomes for AAs\, b) existing treatment research that might represent opportunities for addressing treatment disparities\, c) ongoing efforts in delivering SUD treatment\, including digital technologies\, in Black communities\, and d) effective targets for adaptations and/or implementation research that could improve SUD treatment outcomes for AAs. The objective of this workshop is to identify potential studies that could be conducted in the CTN. \nRegistration: Zoom Registration Link (connection information will be sent in registration confirmation email) \n \n  \n  \n 
URL:https://www.ctnnortheastnode.org/event/reducing-disparities-in-sud-treatment-among-african-americans-a-way-forward-for-ctn-research-day-one/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210304T130000
DTEND;TZID=America/New_York:20210304T170000
DTSTAMP:20260501T045459
CREATED:20210301T180219Z
LAST-MODIFIED:20210301T180219Z
UID:2481-1614862800-1614877200@www.ctnnortheastnode.org
SUMMARY:Reducing Disparities in SUD treatment among African Americans: A way forward for CTN Research - Day Two
DESCRIPTION:CTN Virtual Workshop organized by the Minority Interest Group. \nPrior research found that African Americans (AAs): a) enter treatment later in the course of their addiction trajectory\, b) are more likely to drop out of treatment\, and c) have poorer treatment outcomes than non-Hispanic Whites. \nThis workshop will provide a) an overview of SUD treatments and outcomes for AAs\, b) existing treatment research that might represent opportunities for addressing treatment disparities\, c) ongoing efforts in delivering SUD treatment\, including digital technologies\, in Black communities\, and d) effective targets for adaptations and/or implementation research that could improve SUD treatment outcomes for AAs. The objective of this workshop is to identify potential studies that could be conducted in the CTN. \nRegistration: Zoom Registration Link (connection information will be sent in registration confirmation email) \n \n 
URL:https://www.ctnnortheastnode.org/event/reducing-disparities-in-sud-treatment-among-african-americans-a-way-forward-for-ctn-research-day-two/
CATEGORIES:Clinical Trials Network
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210305T130000
DTEND;TZID=America/New_York:20210305T150000
DTSTAMP:20260501T045459
CREATED:20210111T025721Z
LAST-MODIFIED:20210111T025721Z
UID:2328-1614949200-1614956400@www.ctnnortheastnode.org
SUMMARY:Wraparound Virtual Training Series
DESCRIPTION:Wraparound is a method of engaging children and youth with the highest levels of behavioral health needs\, and their families\, so that they can live in their homes and communities and realize their dreams. We will specialize our focus on parents/family members\, children\, youth\, and young adults impacted by opioid addiction and substance use challenges. \nRegister Here
URL:https://www.ctnnortheastnode.org/event/wraparound-virtual-training-series-6/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210311T120000
DTEND;TZID=America/New_York:20210311T130000
DTSTAMP:20260501T045459
CREATED:20210310T174935Z
LAST-MODIFIED:20210310T180017Z
UID:2488-1615464000-1615467600@www.ctnnortheastnode.org
SUMMARY:Indigenous Rights and Research
DESCRIPTION:Presenter \nMAILE TAUALII\, PhD\, MPH\nAssistant Clinical Investigator\, Center for Integrated Health Care Research (CIHR) Hawaii Permanente Medical Group\nAssistant Professor of Public Health\, Office of Public Health Studies\nAssistant Professor and Chair of Native Hawaiian and Indigenous Health University of Hawai‘i \n\n\n\n\n\nPlease email epidemiology@dartmouth.edu to RSVP or for additional details and seminar materials.
URL:https://www.ctnnortheastnode.org/event/indigenous-rights-and-research/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210311T120000
DTEND;TZID=America/New_York:20210311T130000
DTSTAMP:20260501T045459
CREATED:20210310T180418Z
LAST-MODIFIED:20210310T180418Z
UID:2508-1615464000-1615467600@www.ctnnortheastnode.org
SUMMARY:Science Series: Injectable Extended-Release Buprenorphine Treatment in the Fentanyl Era
DESCRIPTION:Presenter \nJohn J. Mariani\, MD\nDirector\, Substance Treatment and Research and Services (STARS)\nAssociate Professor of Clinical Psychiatry at Columbia University Irving Medical Center/New York State Psychiatry Institute \nTopic \nReview of:\n•Frequency of injection drug use among patients receiving MOUD and potential health consequences\n•Prevalence/incidence of buprenorphine use by non-prescribed routes of administration\n•Potential consequences of buprenorphine injection misuse\n•Therapeutic strategies for identifying and responding to injecting behaviors in MOUD patients \n  \nZoom Link: https://dartmouth.zoom.us/j/423790798?pwd=MEQ0VklVRFJrZmJGL1A5MDhROTRkQT09
URL:https://www.ctnnortheastnode.org/event/science-series-injectable-extended-release-buprenorphine-treatment-in-the-fentanyl-era/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210318T120000
DTEND;TZID=America/New_York:20210318T130000
DTSTAMP:20260501T045459
CREATED:20210218T152644Z
LAST-MODIFIED:20210218T153043Z
UID:2460-1616068800-1616072400@www.ctnnortheastnode.org
SUMMARY:Long-Term OUD Medication Management
DESCRIPTION:Matisyahu Shulman\, MD\nAssistant Professor of Clinical Psychiatry\nDepartment of Psychiatry\, Columbia University\nDivision on Substance Use Disorders\nNew York State Psychiatric Institute\,\nColumbia University Irving Medical Center \n\n\n\n\n\n\n\n\n\n\n  \nTopic Description \nReview of \n\nManaging changes in OUD medication type\, formulation\, and dose\nEvidence-base for:\n\nRetention strategies for SL BUP/XR-BUP\, methadone\, XR-NTX\nPatient characteristics related to discontinuation outcomes\nPatient-motivated  discontinuation of:\n\nSL BUP/XR-BUP\, methadone\, XR-NTX\n\n\n\n\nConsiderations based on data related to race/ethnicity\n\n\n\n\n\n\nPresenter Biography\n\n\n\n\n\n\n\n\n\n\nDr. Matis Shulman is a clinician-scientist with a research focus on opioid use disorders clinical trials and the use of technology to enhance implementation\, quality improvement and treatment delivery. He is currently a co-investigator on the leadership team of two large multi-site opioid use disorder treatment trials funded through the National Institute of Health HEAL initiative. The first considers interventions to improve retention on medications for opioid use disorder and tracks outcomes in individuals who chose to discontinue medications for opioid use disorder. The second trial tests the effectiveness and implementation of a rapid approach to detoxification for induction onto long acting injectable naltrexone.Along with his work in clinical research Dr Shulman is actively involved in efforts to increase awareness and treatment quality for substance use disorders. He frequently lectures for both lay and clinical audiences and is on the advisory board of the Communities Confronting Substance Abuse organization (CCSA). He facilitates the CCSA support group for individuals with loved ones and family members suffering from substance use disorders. \n\nRegister here
URL:https://www.ctnnortheastnode.org/event/long-term-oud-medication-management/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210324T120000
DTEND;TZID=America/New_York:20210324T130000
DTSTAMP:20260501T045459
CREATED:20210218T151333Z
LAST-MODIFIED:20210218T151333Z
UID:2452-1616587200-1616590800@www.ctnnortheastnode.org
SUMMARY:Acute Pain Management Following Surgery: Safe Opioid Prescribing and Strategies to Reduce Opioid Overprescribing
DESCRIPTION:Please join us for a UVM CORA Community Rounds Workshop Series session\, “Acute Pain Management Following Surgery: Safe Opioid Prescribing and Strategies to Reduce Opioid Overprescribing” presented by Marjorie Meyer\, MD\, Professor of Obstetrics\, Gynecology\, and Reproductive Sciences\, UVM Larner College of Medicine\, Burlington\, VT. This presentation will outline strategies to optimize pain control and reduce opioid overprescribing in the post-operative period. Learning Objectives: 1) Pre-operative planning: post-operative expectations\, pain control\, and function following surgery\, 2) Recognition of the high-risk patient for opioid misuse following surgery\, 3) Prediction of post-operative pain control needs\, discharge prescription planning\, post-operative pain presenting to the rural primary care provider (ie: not the surgeon)\, 4) Special considerations regarding pain management with surgery\, including patients receiving MOUD. \nThe University of Vermont Center on Rural Addiction (UVM CORA) presents the Community Rounds Workshop Series live monthly. The goal is to provide opportunities for health professionals to learn\, ask questions\, and discuss topics related to science-based best practices for substance use disorder. Participants can expect about 45 minutes of presentation followed by 15 minutes for questions and conversation. A recording of the session and slides will be shared following the presentation. Registered participants will also be added to UVM CORA’s listserv and receive notifications for future events. If you do not wish to be added to our listserv\, please contact us at CORA@uvm.edu. \nCME/CE credits are available for this live webinar. \nRegister
URL:https://www.ctnnortheastnode.org/event/acute-pain-management-following-surgery-safe-opioid-prescribing-and-strategies-to-reduce-opioid-overprescribing/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210325T120000
DTEND;TZID=America/New_York:20210325T130000
DTSTAMP:20260501T045459
CREATED:20210310T175141Z
LAST-MODIFIED:20210310T175141Z
UID:2490-1616673600-1616677200@www.ctnnortheastnode.org
SUMMARY:Triple-negative Breast Cancer among African American Women March 25th Ancestry-related Variation in Breast Cancer Disparities
DESCRIPTION:TENTATIVE \nPresenters \n\n\n\n\nEDITH P. MITCHELL\, MD\, MACP\, FCPP\, FRCP (London)\nClinical Professor\,Medical Oncology Director\, Center to Eliminate Cancer Disparities \nAssociate Director\, Diversity Affairs\nSidney Kimmel Cancer Center at Jefferson 116th President National Medical Association \n\n\n\n\nLISA NEWMAN\, MD\, MPH\, FACS\, FASCO\nChief of the Section of Breast Surgery \nFounding Medical Director\, International Center for the Study of Breast Cancer Subtypes\nNew York-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine \n\n\n\n\n\n\n\n\n\n\n\n\nPlease email epidemiology@dartmouth.edu to RSVP or for additional details and seminar materials.
URL:https://www.ctnnortheastnode.org/event/triple-negative-breast-cancer-among-african-american-women-march-25th-ancestry-related-variation-in-breast-cancer-disparities/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210331T090000
DTEND;TZID=America/New_York:20210331T100000
DTSTAMP:20260501T045459
CREATED:20210106T202924Z
LAST-MODIFIED:20210106T202924Z
UID:2314-1617181200-1617184800@www.ctnnortheastnode.org
SUMMARY:Part 3: Daily Cannabis Use During Pregnancy and Postpartum: Patient\, Provider\, and Budtender Perspectives
DESCRIPTION:This presentation will cover a series of research studies focused on perceptions of risk of cannabis use during pregnancy and postpartum. Research participants included perinatal women\, healthcare providers\, and cannabis retailers in the state of Washington. \nDr. Celestina Barbosa-Leiker is an Associate Professor in the College of Nursing and Vice Chancellor for Research at Washington State University Health Sciences Spokane. Her research focuses on pregnant and parenting women with substance use disorders. \nPresenter: Celestina Barbosa-Leiker\, PhD \nRegister Here \n  \n 
URL:https://www.ctnnortheastnode.org/event/part-3-daily-cannabis-use-during-pregnancy-and-postpartum-patient-provider-and-budtender-perspectives/
CATEGORIES:Other Related
END:VEVENT
END:VCALENDAR